Tang Capital Management’s AstraZeneca AZN Stock Holding History

Tang Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-75,000	Closed	-$11.5M	–	87
2025 Q3	$11.5M	Hold	75,000	–	–	0.44%	57
2025 Q2	$10.5M	Sell	75,000 -50,000	-40%	-$7.01M	0.53%	49
2025 Q1	$18.4M	Buy	125,000 +50,000	+67%	+$7.23M	1.02%	26
2024 Q4	$9.83M	Hold	75,000	–	–	0.65%	42
2024 Q3	$11.7M	Hold	75,000	–	–	0.83%	41
2024 Q2	$11.7M	Hold	75,000	–	–	1.19%	28
2024 Q1	$10.2M	Sell	75,000 -10,000	-12%	-$1.32M	1.06%	32
2023 Q4	$11.4M	Hold	85,000	–	–	1.06%	25
2023 Q3	$11.5M	Hold	85,000	–	–	1.62%	18
2023 Q2	$12.2M	Hold	85,000	–	–	1.79%	18
2023 Q1	$11.8M	Hold	85,000	–	–	1.76%	17
2022 Q4	$11.5M	Buy	85,000 +10,000	+13%	+$1.25M	1.67%	18
2022 Q3	$8.23M	Buy	+75,000	New	+$9.51M	1.01%	28

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Tang Capital Management's AZN Position: Q4 2025 in Review

Tang Capital Management sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 75,000 shares — an estimated $11.5M sold.

Tang Capital Management first reported a position in AZN in Q3 2022 and held it in 13 quarters. The position peaked at $18.4M in Q1 2025. 1,407 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

Tang Capital Management reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
Tang Capital Management sold 75,000 AstraZeneca shares in Q4 2025, an estimated $11.5M.
Tang Capital Management first reported a position in AstraZeneca in Q3 2022 and held it in 13 quarters.
Tang Capital Management's AstraZeneca position peaked at $18.4M in Q1 2025.
1,407 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.